Research

Human biology and AI, studied together

Our scientists publish on human immunology, organoids, and the AI that learns from them. Every paper here comes with an easy-to-understand summary you can match to your background, whether you’re curious, a biologist or an AI researcher, so you can see what we found and why it matters.

Published inNature ProtocolsNatureNature Cell BiologyCancer DiscoveryNature BiotechnologyCell Reportsnpj VaccinesPLOS PathogensCellGenome MedicineFrontiers in MicrobiologyScience SignalingInfection and ImmunityJournal of Theoretical BiologyFibrogenesis & Tissue RepaireLifeJournal of Gastroenterology and HepatologyScienceMolecular and Cellular BiologyThe Journal of ImmunologyPNASFEMS Microbiology Letters

All publications

Showing all 28 publications

2025

Protocol

Nature Protocols

Peer-reviewed

Biology

Production of human blood-generating heart-forming organoids and sample preparation for advanced imaging

Miriana DardanoParallel BioMiriana DardanoScientist, Liam Wilson, Robert Zweigerdt, Lika Drakhlis

Explain at my level

A result other labs cannot reproduce is not much use. This is the step-by-step recipe for growing the blood-making heart organoids and preparing them for imaging, published so that anyone can run it.

Why it matters

Makes the organoid model reproducible in other labs, which is what turns a result into a usable method.

Cite this

Dardano M, Wilson L, Zweigerdt R, Drakhlis L. Production of human blood-generating heart-forming organoids and sample preparation for advanced imaging. Nat Protoc. 2025.

2025

Journal article

Nature

Peer-reviewed

Biology

Cancer cells impair monocyte-mediated T cell stimulation to evade immunity

Anais Elewaut, Guillem Estivill, Felix Bayerl, Leticia Castillon, Maria Novatchkova, Elisabeth Pottendorfer, Lisa Hoffmann-Haas, Martin Schönlein, Trung Viet Nguyen, Martin Lauss, Francesco Andreatta, Milica Vulin, Izabela Krecioch, Jonas Bayerl, Anna-Marie Pedde, Naomi Fabre, Felix Holstein, Shona CroninParallel BioShona Cronin, PhDScientist, Sarah Rieser, Denarda Dangaj Laniti, David Barras, George Coukos, Camelia Quek, Xinyu Bai, Miquel Muñoz i Ordoño, Thomas Wiesner, Johannes Zuber, Göran Jönsson, Jan P. Böttcher, Sakari Vanharanta, Anna C. Obenauf

Explain at my level

T cells need to be re-activated once they are inside a tumor, or they stop working. This study found the cells that do the re-activating are a type nobody expected, and that cancer cells shut them down by releasing one particular molecule. Block that molecule and the T cells come back to life.

Why it matters

Identifies how tumors switch off the immune cells that keep T cells working, and how to switch them back on.

Cite this

Elewaut A, Estivill G, Bayerl F, Castillon L, Novatchkova M, Pottendorfer E, et al. Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature. 2025;637(8046):716–725.

2024

Journal article

Nature Cell Biology

Peer-reviewed

Biology

Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart

Miriana DardanoParallel BioMiriana DardanoScientist, Felix Kleemiß, Maike Kosanke, Dorina Lang, Liam Wilson, Annika Franke, Jana Teske, Akshatha Shivaraj, Jeanne de la Roche, Martin Fischer, Lucas Lange, Axel Schambach, Lika Drakhlis, Robert Zweigerdt

Explain at my level

Long before bone marrow takes over, a human embryo makes its first blood cells next to the developing heart. Nobody could watch that happen, because it happens inside an embryo. This team grew it in a dish: an organoid with heart muscle, blood vessel lining and blood-forming tissue all developing together, in the right arrangement.

Why it matters

Recreates the earliest stage of human blood formation, which has been inaccessible because it happens inside the embryo.

Cite this

Dardano M, Kleemiß F, Kosanke M, Lang D, Wilson L, Franke A, Teske J, Shivaraj A, de la Roche J, Fischer M, Lange L, Schambach A, Drakhlis L, Zweigerdt R. Blood-generating heart-forming organoids recapitulate co-development of the human haematopoietic system and the embryonic heart. Nat Cell Biol. 2024;26:1984–1996.

2023

Journal article

Cancer Discovery

Peer-reviewed

Biology

Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers

Lukas Leiendecker, Tobias Neumann, Pauline S. Jung, Shona CroninParallel BioShona Cronin, PhDScientist, Thomas L. Steinacker, Alexander Schleiffer, Michael Schutzbier, Karl Mechtler, Thibault Kervarrec, Estelle Laurent, Kamel Bachiri, Etienne Coyaud, Rajmohan Murali, Klaus J. Busam, Babak Itzinger-Monshi, Reinhard Kirnbauer, Lorenzo Cerroni, Eduardo Calonje, Arno Rütten, Frank Stubenrauch, Klaus G. Griewank, Thomas Wiesner, Anna C. Obenauf

Explain at my level

The team searched cancer genome data for traces of 6,000 human viruses across 19 kinds of skin cancer. In one rare, aggressive cancer of the fingers and toes they found the same virus in 96% of samples, a strain previously thought harmless.

Why it matters

Identifies a new cancer-causing virus by reading data that standard analysis throws away.

Cite this

Leiendecker L, Neumann T, Jung PS, Cronin SM, Steinacker TL, Schleiffer A, et al. Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers. Cancer Discov. 2023;13(1):70–84.

2021

Journal article

Nature Biotechnology

Peer-reviewed

Biology

Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters

Christian Umkehrer, Felix Holstein, Laura Formenti, Julian Jude, Kimon Froussios, Tobias Neumann, Shona CroninParallel BioShona Cronin, PhDScientist, Lisa Haas, Jesse J. Lipp, Thomas R. Burkard, Michaela Fellner, Thomas Wiesner, Johannes Zuber, Anna C. Obenauf

Explain at my level

Normally you can label millions of cells and track which ones survive a drug, but you cannot get those specific cells back alive to study them. This method, called CaTCH, lets you reach into the population and retrieve any clone you want, including ones making up one cell in a hundred thousand.

Why it matters

Makes it possible to retrieve and study the rare cells that survive a treatment, instead of only counting them.

Cite this

Umkehrer C, Holstein F, Formenti L, Jude J, Froussios K, Neumann T, Cronin SM, Haas L, Lipp JJ, Burkard TR, Fellner M, Wiesner T, Zuber J, Obenauf AC. Isolating live cell clones from barcoded populations using CRISPRa-inducible reporters. Nat Biotechnol. 2021;39(2):174–178.

2020

Preprint

bioRxiv

Biology

Optimization and scaling of patient-derived brain organoids uncovers deep phenotypes of disease

Kevan Shah, Rishi Bedi, Alex Rogozhnikov, Pavan Ramkumar, Zhixiang Tong, Brian Rash, Morgan Stanton, Jordan Sorokin, Cagsar Apaydin, Anthony Batarse, Julia Bergamaschi, Robert Blattner, Spencer Brown, Anthony Bosshardt, Carlos Castrillo, Brenda Dang, Shiron Drusinsky, Luigi Enriquez, David Grayson, Juliana HilliardParallel BioJuliana HilliardCo-Founder and Chief Science Officer, Pei-Ken Hsu, Chili Johnson, Ryan Jones, Andy Lash, Chia-Yao Lee, Kelly Li, Austin McKay, Elliot Mount, Justin Nicola, Ismael Oumzil, Justin Paek, Deborah Pascoe, Arden Piepho, Sean Poust, Daphne Quang, Matthew Schultz, Jessica Sims, Patrick Taylor, Geffen Treiman, Oliver Wueseke, Noah Young, Alex Pollen, Doug Flanzer, Daniel Chao, Gaia Skibinski, Saul Kato, G. Sean Escola

Explain at my level

Lab-grown mini-brains vary a lot from batch to batch, which makes them hard to trust as disease models. This team built a robot system to grow and photograph them at scale, used machine learning to work out exactly where the variability comes from, and then cut it down enough to detect a disease signature nobody had been able to see reliably before.

Why it matters

Tackles the problem that makes organoids hard to use at scale: knowing how much of what you measure is the biology and how much is the batch.

Cite this

Shah K, Bedi R, Rogozhnikov A, Ramkumar P, Tong Z, Rash B, et al. Optimization and scaling of patient-derived brain organoids uncovers deep phenotypes of disease. bioRxiv. 2020. doi:10.1101/2020.08.26.251611.

2019

Journal article

Cell Reports

Peer-reviewed

Biology

Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D

Christian W. Johnson, Yi-Jang LinParallel BioYi-Jang Lin, PhDSenior Scientist, Derion Reid, Jillian Parker, Spiro Pavlopoulos, Patrick Dischinger, Carrie Graveel, Andrew J. Aguirre, Matthew Steensma, Kevin M. Haigis, Carla Mattos

Explain at my level

One particular Ras mutation, G13D, shows up in a quarter of colorectal cancers but almost never elsewhere. This study solved the structures to find out why, and the answer is in the shape of the protein's active site, which is loosened in one version of Ras but not in its near-identical relatives.

Why it matters

Explains why one cancer mutation is common in colorectal cancer and rare everywhere else, at the level of protein structure.

Cite this

Johnson CW, Lin YJ, Reid D, Parker J, Pavlopoulos S, Dischinger P, Graveel C, Aguirre AJ, Steensma M, Haigis KM, Mattos C. Isoform-Specific Destabilization of the Active Site Reveals a Molecular Mechanism of Intrinsic Activation of KRas G13D. Cell Rep. 2019;28(6):1538–1550.e7.

2019

Journal article

Cancer Discovery

Peer-reviewed

Biology

Tissue-Specific Oncogenic Activity of KRAS A146T

Emily J. Poulin, Asim K. Bera, Jia Lu, Yi-Jang LinParallel BioYi-Jang Lin, PhDSenior Scientist, Samantha Dale Strasser, Joao A. Paulo, Tannie Q. Huang, Carolina Morales, Wei Yan, Joshua Cook, Jonathan A. Nowak, Douglas K. Brubaker, Brian A. Joughin, Christian W. Johnson, Rebecca A. DeStefanis, Phaedra C. Ghazi, Sudershan Gondi, Thomas E. Wales, Roxana E. Iacob, Lana Bogdanova, Jessica J. Gierut, Yina Li, John R. Engen, Pedro A. Perez-Mancera, Benjamin S. Braun, Steven P. Gygi, Douglas A. Lauffenburger, Kenneth D. Westover, Kevin M. Haigis

Explain at my level

KRAS is the most commonly mutated cancer gene, but different versions of the mutation show up in different organs. This study asked why, and found the answer is not chance: each mutant protein behaves differently, and that behavior determines which tissue it can turn cancerous.

Why it matters

Explains why the same cancer gene causes different cancers depending on exactly how it is mutated.

Cite this

Poulin EJ, Bera AK, Lu J, Lin YJ, Strasser SD, Paulo JA, et al. Tissue-Specific Oncogenic Activity of KRAS-A146T. Cancer Discov. 2019;9(6):738–755.

2019

Journal article

npj Vaccines

Peer-reviewed

Biology

Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques

Patricia A. Darrah, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Pauline Maiello, Hannah P. Gideon, Amy J. Myers, Mark A. Rodgers, Joshua A. Hackney, Thomas Lindenstrom, Thomas Evans, Charles A. Scanga, Victor Prikhodko, Peter Andersen, Philana Ling Lin, Dominick Laddy, Mario Roederer, Robert A. Seder, JoAnne L. Flynn

Explain at my level

BCG is the only approved TB vaccine and it protects unevenly. This study tried to strengthen it with a booster shot, testing several boosters in 64 monkeys. None of them worked better than BCG alone, and one even seemed to weaken the protection BCG gave.

Why it matters

Shows that a strong immune response does not mean protection, which is a core problem in picking what to advance into trials.

Cite this

Darrah PA, DiFazio RM, Maiello P, Gideon HP, Myers AJ, Rodgers MA, Hackney JA, Lindenstrom T, Evans T, Scanga CA, Prikhodko V, Andersen P, Lin PL, Laddy D, Roederer M, Seder RA, Flynn JL. Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaques. npj Vaccines. 2019;4:21.

2019

Book chapter

Curious2018 · Springer

Biology

Integrating Modern Immunology into Medicine

Mark M. Davis, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO

Explain at my level

An essay on closing the gap between immunology research and the clinic: how new ways of measuring the human immune system, many cell types and molecules in many people at once, could make immune health something doctors routinely read and act on.

Why it matters

Frames the immune system as a measurable, central factor in health and disease, a view that runs through Parallel Bio’s work.

Cite this

Davis MM, DiFazio RM. Integrating Modern Immunology into Medicine. In: Curious2018. Springer, Cham (2019), pp. 41–45.

Summary written by Parallel Bio, reviewed by Robert DiFazio.

2018

Journal article

PLOS Pathogens

Peer-reviewed

Biology

Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques

Anthony M. Cadena, Forrest F. Hopkins, Pauline Maiello, Allison F. Carey, Eileen A. Wong, Constance J. Martin, Hannah P. Gideon, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Peter Andersen, Philana Ling Lin, Sarah M. Fortune, JoAnne L. Flynn

Explain at my level

If you already have a tuberculosis infection, are you protected from catching it again? The team tagged two strains of the bacterium with genetic barcodes so they could tell them apart, then infected monkeys a second time. The existing infection blocked the new one almost completely.

Why it matters

Shows the immune system can block reinfection, which sets a benchmark for what a successful vaccine would have to match.

Cite this

Cadena AM, Hopkins FF, Maiello P, Carey AF, Wong EA, Martin CJ, Gideon HP, DiFazio RM, Andersen P, Lin PL, Fortune SM, Flynn JL. Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaques. PLoS Pathog. 2018;14(10):e1007305.

2018

Journal article

Cell

Peer-reviewed

Biology

Centromeres License the Mitotic Condensation of Yeast Chromosome Arms

Tom KruitwagenParallel BioTom KruitwagenDirector, Stem Cell Biology, Pierre Chymkowitch, Annina Denoth-Lippuner, Jorrit Enserink, Yves Barral

Explain at my level

Cells have to tell their own DNA apart from foreign DNA that gets in, such as from a virus. This study found yeast cells use a surprising marker to do it: the centromere, a structure that was thought to be only for pulling chromosomes apart during division. DNA without one fails to fold up and gets discarded into just one daughter cell.

Why it matters

Identifies a defense mechanism cells use to recognize and discard foreign DNA, in a place nobody was looking.

Cite this

Kruitwagen T, Chymkowitch P, Denoth-Lippuner A, Enserink J, Barral Y. Centromeres License the Mitotic Condensation of Yeast Chromosome Arms. Cell. 2018;175(3):780–795.e15.

2018

Review

Genome Medicine

Peer-reviewed

Biology

Advanced model systems and tools for basic and translational human immunology

Lisa E. Wagar, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Mark M. Davis

Explain at my level

Much of what we know about the immune system comes from mice, and mouse immunity differs from ours in ways that matter for drugs and vaccines. This review surveys the tools for studying human immunity directly, from organoids and tissue models to detailed single-cell measurements, and argues for making human systems the default.

Why it matters

The scientific case for the approach Parallel Bio was founded on: study human immunity in human systems.

Cite this

Wagar LE, DiFazio RM, Davis MM. Advanced model systems and tools for basic and translational human immunology. Genome Medicine 10, 73 (2018).

Summary written by Parallel Bio, reviewed by Robert DiFazio.

2018

Journal article

Frontiers in Microbiology

Peer-reviewed

Biology

Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes

Louis R. Joslyn, Elsje Pienaar, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Sara Suliman, Benjamin M. Kagina, JoAnne L. Flynn, Thomas J. Scriba, Jennifer J. Linderman, Denise E. Kirschner

Explain at my level

The same vaccine gives different results in monkeys and in people. This study built a mathematical model of how T cells respond to vaccination, fitted it to both monkey and human blood data, and used it to work out which differences between the species explain the gap.

Why it matters

Makes the gap between monkey and human vaccine responses explicit and measurable rather than assumed.

Cite this

Joslyn LR, Pienaar E, DiFazio RM, Suliman S, Kagina BM, Flynn JL, Scriba TJ, Linderman JJ, Kirschner DE. Integrating Non-human Primate, Human, and Mathematical Studies to Determine the Influence of BCG Timing on H56 Vaccine Outcomes. Front Microbiol. 2018;9:1734.

2018

Journal article

Science Signaling

Peer-reviewed

Biology

Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis

Jesse Lyons, Douglas K. Brubaker, Phaedra C. Ghazi, Katherine R. Baldwin, Amanda Edwards, Myriam Boukhali, Samantha Dale Strasser, Lucia Suarez-Lopez, Yi-Jang LinParallel BioYi-Jang Lin, PhDSenior Scientist, Vijay Yajnik, Joseph L. Kissil, Wilhelm Haas, Douglas A. Lauffenburger, Kevin M. Haigis

Explain at my level

Inflammatory bowel disease has few treatment options. This study measured three different layers of biology (genes, proteins and the chemical switches on them) in the same tissue samples, which let them follow the signal from one layer to the next and spot a pathway that no single layer revealed. Blocking it suppressed the disease in mice.

Why it matters

Finds a drug target for inflammatory bowel disease that no single type of measurement would have revealed.

Cite this

Lyons J, Brubaker DK, Ghazi PC, Baldwin KR, Edwards AL, Boukhali M, Strasser SD, Suarez-Lopez L, Lin YJ, Yajnik V, Kissil JL, Haas W, Lauffenburger DA, Haigis KM. Integrated in vivo multiomics analysis identifies p21-activated kinase signaling as a driver of colitis. Sci Signal. 2018;11(519):eaan3580.

2018

Journal article

Infection and Immunity

Peer-reviewed

Biology

Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison

Pauline Maiello, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Anthony M. Cadena, Mark A. Rodgers, Philana Ling Lin, Charles A. Scanga, JoAnne L. Flynn

Explain at my level

Two closely related species of monkey are both used to study tuberculosis. This study compared them head to head and found they get strikingly different versions of the disease: one species controls the infection far better than the other. Which animal you pick changes the answer you get.

Why it matters

Quantifies how much the choice of animal, not the biology being studied, determines the result.

Cite this

Maiello P, DiFazio RM, Cadena AM, Rodgers MA, Lin PL, Scanga CA, Flynn JL. Rhesus Macaques Are More Susceptible to Progressive Tuberculosis than Cynomolgus Macaques: a Quantitative Comparison. Infect Immun. 2018;86(2):e00505-17.

2017

Journal article

Journal of Theoretical Biology

Peer-reviewed

Biology

Identifying mechanisms driving formation of granuloma-associated fibrosis during Mycobacterium tuberculosis infection

Hayley C. Warsinske, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Jennifer J. Linderman, JoAnne L. Flynn, Denise E. Kirschner

Explain at my level

Scar tissue around a tuberculosis lesion can help by walling off the infection, or hurt by stiffening the lung. This study built a computer simulation of a lesion forming, cell by cell, to work out which signals push it toward each kind of scarring.

Why it matters

Explains how the same infection produces two different kinds of lung scarring, which determines how much lung function a patient keeps.

Cite this

Warsinske HC, DiFazio RM, Linderman JJ, Flynn JL, Kirschner DE. Identifying mechanisms driving formation of granuloma-associated fibrosis during Mycobacterium tuberculosis infection. J Theor Biol. 2017;429:1–17.

2016

Journal article

PLOS Pathogens

Peer-reviewed

Biology

PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis

Philana Ling Lin, Pauline Maiello, Hannah P. Gideon, M. Teresa Coleman, Anthony M. Cadena, Mark A. Rodgers, Robert Gregg, Melanie O’Malley, Jaime Tomko, Daniel Fillmore, L. James Frye, Tara Rutledge, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Christopher Janssen, Edwin Klein, Peter L. Andersen, Sarah M. Fortune, JoAnne L. Flynn

Explain at my level

More than two billion people carry a dormant tuberculosis infection, and only some will ever get sick. This study used scans to find which animals were at high risk before anything happened, and the scans predicted reactivation with about 92% accuracy.

Why it matters

Reframes latent tuberculosis as a spectrum with measurable risk rather than a single dormant state.

Cite this

Lin PL, Maiello P, Gideon HP, Coleman MT, Cadena AM, Rodgers MA, Gregg R, O'Malley M, Tomko J, Fillmore D, Frye LJ, Rutledge T, DiFazio RM, Janssen C, Klein E, Andersen PL, Fortune SM, Flynn JL. PET CT Identifies Reactivation Risk in Cynomolgus Macaques with Latent M. tuberculosis. PLoS Pathog. 2016;12(7):e1005739.

2016

Journal article

Fibrogenesis & Tissue Repair

Peer-reviewed

Biology

Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis

Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Joshua T. Mattila, Edwin C. Klein, Lauren R. Cirrincione, Mondraya Howard, Eileen A. Wong, JoAnne L. Flynn

Explain at my level

The body walls off tuberculosis bacteria inside lung structures called granulomas. This study found that after antibiotic treatment, granulomas shift toward scar-like tissue, and that the signaling molecule TGF-β tracks closely with that change.

Why it matters

Shows how the immune system reshapes tissue after an infection is treated, which bears on lasting lung damage and on how we judge whether treatment worked.

Cite this

DiFazio RM, Mattila JT, Klein EC, Cirrincione LR, Howard M, Wong EA, Flynn JL. Active transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosis. Fibrogenesis & Tissue Repair 9, 6 (2016).

Summary written by Parallel Bio, reviewed by Robert DiFazio.

2015

Journal article

Science Signaling

Peer-reviewed

Biology

Network-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epithelium

Jessica J. Gierut, Levi B. Wood, Ken S. Lau, Yi-Jang LinParallel BioYi-Jang Lin, PhDSenior Scientist, Casie Genetti, Ahmed A. Samatar, Douglas A. Lauffenburger, Kevin M. Haigis

Explain at my level

Drugs that hit the same target are usually assumed to do the same thing. This study tested several inhibitors of one signaling pathway in the gut lining and found they had quite different effects on cell death, because each one also perturbs the rest of the network in its own way.

Why it matters

Shows that two drugs aimed at the same target can produce opposite outcomes in tissue.

Cite this

Gierut JJ, Wood LB, Lau KS, Lin YJ, Genetti C, Samatar AA, Lauffenburger DA, Haigis KM. Network-level effects of kinase inhibitors modulate TNF-α-induced apoptosis in the intestinal epithelium. Sci Signal. 2015;8(407):ra129.

2015

Journal article

eLife

Peer-reviewed

Biology

Axial contraction and short-range compaction of chromatin synergistically promote mitotic chromosome condensation

Tom KruitwagenParallel BioTom KruitwagenDirector, Stem Cell Biology, Annina Denoth-Lippuner, Bryan J. Wilkins, Heinz Neumann, Yves Barral

Explain at my level

Before a cell divides, it has to pack its long, tangled DNA into compact chromosomes that can be pulled cleanly into the two new cells. Working in yeast, this study found that the packing happens in two separate ways at once: the DNA fiber squeezes itself tighter locally, while a protein machine called condensin shortens each chromosome along its length. Either one alone is enough to get by; lose both and cells divide badly and often die.

Why it matters

Shows that cells shape their chromosomes for division with two independent backup systems, which is why the role of each only becomes visible when both fail.

Key takeaways

  1. Mitotic chromosome condensation involves two separate processes: short-range compaction of the chromatin fiber and condensin-driven axial contraction of chromosome arms.
  2. Short-range compaction is triggered in early anaphase by phosphorylation of histone H3 at serine 10 and deacetylation of histone H4.
  3. Losing either process alone has little visible effect; losing both causes synergistic defects in chromosome segregation and cell viability.

Cite this

Kruitwagen T, Denoth-Lippuner A, Wilkins BJ, Neumann H, Barral Y. Axial contraction and short-range compaction of chromatin synergistically promote mitotic chromosome condensation. eLife 4, e10396 (2015).

2015

Journal article

Nature

Peer-reviewed

Biology

EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors

Christine M. Fillmore, Chunxiao Xu, Pooja T. Desai, Joanne M. Berry, Samuel P. Rowbotham, Yi-Jang LinParallel BioYi-Jang Lin, PhDSenior Scientist, Haikuo Zhang, Victor E. Marquez, Peter S. Hammerman, Kwok-Kin Wong, Carla F. Kim

Explain at my level

A standard chemotherapy drug works well in only a minority of lung cancer patients. This study found that adding a second drug makes the chemotherapy work in tumors carrying particular mutations, and makes it work worse in tumors without them. Which group a patient is in can be read off their tumor's genetics.

Why it matters

Identifies which lung cancer patients a drug combination would help and which it would harm, from their tumor genetics.

Cite this

Fillmore CM, Xu C, Desai PT, Berry JM, Rowbotham SP, Lin YJ, Zhang H, Marquez VE, Hammerman PS, Wong KK, Kim CF. EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors. Nature. 2015;520(7546):239–242.

2014

Journal article

Journal of Gastroenterology and Hepatology

Peer-reviewed

Biology

Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma

Da-Liang Ou, Chun-Jung Chang, Yung-Ming Jeng, Yi-Jang LinParallel BioYi-Jang Lin, PhDSenior Scientist, Zhong-Zhe Lin, Anita K Gandhi, Sheng-Chieh Liao, Zi-Ming Huang, Chiun Hsu, Ann-Lii Cheng

Explain at my level

Two liver cancer drugs worked better together than either did alone. The reason turned out to be immune, not direct: the combination brought more killer T cells into the tumor. When those T cells were removed, the benefit disappeared entirely.

Why it matters

Shows a drug combination working through the immune system rather than directly on the tumor.

Cite this

Ou DL, Chang CJ, Jeng YM, Lin YJ, Lin ZZ, Gandhi AK, Liao SC, Huang ZM, Hsu C, Cheng AL. Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma. J Gastroenterol Hepatol. 2014;29(12):2021–2031.

2014

Journal article

Science

Peer-reviewed

Biology

A Cascade of Histone Modifications Induces Chromatin Condensation in Mitosis

Bryan J. Wilkins, Nils A. Rall, Yogesh Ostwal, Tom KruitwagenParallel BioTom KruitwagenDirector, Stem Cell Biology, Kyoko Hiragami-Hamada, Marco Winkler, Yves Barral, Wolfgang Fischle, Heinz Neumann

Explain at my level

Before a cell divides, its DNA packs itself down into compact bundles. This study traced the chain of chemical events that sets the packing off, using light-activated crosslinkers to catch proteins in the act of touching each other inside living cells.

Why it matters

Traces the chemical chain that packs DNA for cell division, and provides a way to watch protein contacts happen in living cells.

Cite this

Wilkins BJ, Rall NA, Ostwal Y, Kruitwagen T, Hiragami-Hamada K, Winkler M, Barral Y, Fischle W, Neumann H. A Cascade of Histone Modifications Induces Chromatin Condensation in Mitosis. Science. 2014;343(6166):77–80.

2013

Journal article

Molecular and Cellular Biology

Peer-reviewed

Biology

Quantitative analysis of chromosome condensation in fission yeast

Boryana Petrova, Sascha Dehler, Tom KruitwagenParallel BioTom KruitwagenDirector, Stem Cell Biology, Jean-Karim Hériché, Kota Miura, Christian H. Haering

Explain at my level

To study how chromosomes fold, you first need a way to measure folding. This study built one: tag two spots on the same chromosome with fluorescent markers, then track the distance between them in a living cell, frame by frame.

Why it matters

Turns chromosome folding from something you look at into something you measure, which is what made the later screens possible.

Cite this

Petrova B, Dehler S, Kruitwagen T, Hériché JK, Miura K, Haering CH. Quantitative analysis of chromosome condensation in fission yeast. Mol Cell Biol. 2013;33(5):984–998.

2013

Journal article

The Journal of Immunology

Peer-reviewed

Biology

IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection

Angela M Green, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, JoAnne L Flynn

Explain at my level

Many kinds of immune cell can make IFN-γ, a signal that helps control tuberculosis. This study asked whether the signal is enough on its own, or whether it has to come from one particular cell type. It had to come from CD4 T cells; the same molecule from other sources did not substitute.

Why it matters

Shows that where an immune signal comes from matters as much as how much of it there is.

Cite this

Green AM, DiFazio R, Flynn JL. IFN-γ from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol. 2013;190(1):270–277.

2012

Journal article

PNAS

Peer-reviewed

Biology

Wnt/β-catenin signaling requires interaction of the Dishevelled DEP domain and C terminus with a discontinuous motif in Frizzled

Daniele V. F. Tauriello, Ingrid Jordens, Katharina Kirchner, Jerry W. Slootstra, Tom KruitwagenParallel BioTom KruitwagenDirector, Stem Cell Biology, Britta A. M. Bouwman, Maria Noutsou, Stefan G. D. Rüdiger, Klaus Schwamborn, Alexandra Schambony, Madelon M. Maurice

Explain at my level

Wnt is one of the signals that tells cells what to become during development, and faults in it drive cancer. This study worked out how two of the proteins in the chain actually grip each other: not at one site, but at three separate stretches that have to work together.

Why it matters

Maps a developmental signaling step at the level of detail needed to target it with a drug.

Cite this

Tauriello DVF, Jordens I, Kirchner K, Slootstra JW, Kruitwagen T, Bouwman BAM, Noutsou M, Rüdiger SGD, Schwamborn K, Schambony A, Maurice MM. Wnt/β-catenin signaling requires interaction of the Dishevelled DEP domain and C terminus with a discontinuous motif in Frizzled. Proc Natl Acad Sci USA. 2012;109(14):E812–E820.

2011

Journal article

FEMS Microbiology Letters

Peer-reviewed

Biology

Toxin–antitoxin systems are prevalent and transcribed in clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus

Julia J. Williams, Elizabeth M. Halvorsen, Ellen M. Dwyer, Robert DiFazioParallel BioRobert DiFazio, PhDCo-Founder and CEO, Paul J. Hergenrother

Explain at my level

Many bacteria carry a built-in self-destruct system: a toxin kept in check by a matching antitoxin. This study found these systems are common and switched on in drug-resistant hospital bacteria, pointing to a new way to kill them: release the toxin.

Why it matters

Identified a potential new weak point in “superbugs” that resist today’s antibiotics.

Cite this

Williams JJ, Halvorsen EM, Dwyer EM, DiFazio RM, Hergenrother PJ. Toxin–antitoxin (TA) systems are prevalent and transcribed in clinical isolates of Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. FEMS Microbiology Letters 322, 41–50 (2011).

Summary written by Parallel Bio, reviewed by Robert DiFazio.

Work with our scientists

We collaborate with academic labs, pharma partners and AI researchers. Datasets and code from our papers are available where marked; for anything else, ask us.

New papers by email

Thanks. We’ll email you when we publish something new.
Something went wrong. Please try again.